CLONING AND CHARACTERIZATION OF NOVEL DISINTEGRINS FROM AGKISTRODON HALYS VENOM

Citation
Ds. Park et al., CLONING AND CHARACTERIZATION OF NOVEL DISINTEGRINS FROM AGKISTRODON HALYS VENOM, Molecules and Cells, 8(5), 1998, pp. 578-584
Citations number
35
Categorie Soggetti
Biology,"Cell Biology
Journal title
ISSN journal
10168478
Volume
8
Issue
5
Year of publication
1998
Pages
578 - 584
Database
ISI
SICI code
1016-8478(1998)8:5<578:CACOND>2.0.ZU;2-I
Abstract
Snake venom disintegrins act as potent inhibitors of platelet aggregat ion. In this report, we isolated genes encoding novel members of disin tegrins through the screening of Agkistrodon Italys venom gland cDNA l ibrary. Subsequent characterization of positives revealed the presence of distinct disintegrins named salmosin1, 2, and 3, each containing a characteristic RGD/KGD sequence essential for the binding to integrin s, Whereas salmosin1 was identical to previously described salmosin pu rified from A. halys venom, salmosin2 and salmosin3 were predicted to be a novel, 73 amino acid protein with a KGD sequence, and an 80 amino acid protein with an additional 7th disulfide bond, respectively. Tak en together, this is the first report describing 3 unique disintegrins , namely, salmosin1 with RGD, salmosin2 with KGD and salmosin3 with 7 disulfide bonds are found in a single species of venom. Subsequently, to compare the platelet aggregation inhibitory potential of the recomb inant protein with that of natural protein, salmosin1 was expressed in E. coli and purified to homogeneity, Recombinant and natural salmosin 1 inhibited the binding of alpha(IIb)beta(3) to fibrinogen with an alm ost identical IC50 value of 2.2 nM and 4.5 nM respectively. Moreover, recombinant salmosin1 displayed an IC50 value approximately 5-fold low er than flavoridin, which was previously described as the most potent venom disintegrin so far. In conclusion, we identified 3 disintegrins with distinct properties through the molecular cloning approach and fo und that the recombinant salmosin1 retained one of the most potent alp ha(IIb)beta(3) antagonist activity.